Signant Health Appoints Lawrence Miller as Chief Technology Officer
LONDON & PHILADELPHIA – June 13, 2019: Signant Health,
formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology
Officer. Signant unites electronic Clinical Outcomes Assessment (eCOA),
eConsent, Patient Engagement, Interactive Response Technology (IRT),
Clinical Supply Management and Endpoint Quality into the industry’s most
comprehensive patient-centric suite of technology solutions and
services. An accomplished innovator, Miller brings unique vision and
expertise to a Signant team already committed to advancing clinical
research with its next-generation technology portfolio. More info >>
PhlexEarchive: The Right Solution for Electronic Archiving of TMF Content
Many sponsor organizations have already recognized the value of moving from paper to electronic Trial Master Files (eTMFs). But few sponsors have taken a more holistic approach to the TMF lifecycle and looked at the entire process from study start-up through archiving of the TMF in electronic format, also known as e-archiving. The recurring value of managing, tracking, maintaining and accessing electronic files should not stop at the point of archiving. All of the challenges of managing an active paper TMF carry through to a paper archive. All of the benefits of an electronic TMF also carry through to the electronic archive.
As companies look to move their compliance assets to secure, long-term storage, it is important to consider ongoing compliance requirements, security, accessibility, efficiency and costs of archiving TMF content in a digital format.
More info >>
The 20th annual World Vaccine Congress Europe is taking place 28-31 Oct in Barcelona.
It’s the biggest and most established European vaccine event with over 250 speakers,
700+ senior vaccine attendees, hundreds of networking hours.
It cover key topics across the complete vaccine value chain bringing together:
• big pharma
• big biotech
• SME Biotech
and the wider service provider community and their partners to discuss scientific,
clinical and strategic advances and opportunities.
The event has already confirmed over 200 speakers from Human Vaccine Project, OECD,
CEPI, European Commission, FDA, WHO, OECD, NIH, GSK and many more…
There is a Super Early Bird offer available – Find Out More
More info >>